ArticleMicrobial cell factories2026
Overexpression of msnA reprograms metabolism to enhance recombinant protein secretion across Aspergillus species.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundFilamentous fungi, particularly Aspergillus species, play a crucial role in industrial biotechnology due to their exceptional protein secretion systems and robust metabolic adaptability. However, variability in heterologous protein production presents a major bottleneck.
resultsHere, we combine multi-omics analyses and synthetic biology to identify msnA as a key regulator of recombinant protein production in Aspergillus spp. Overexpression of msnA enhances secretion of diverse proteins (e.g., glycoside hydrolases, fluorescent proteins) by up to 2.8-fold in A. nidulans, A. niger, and A. oryzae, demonstrating functional conservation across Aspergillus species. Mechanistically, transcriptomic studies reveal that msnA reprograms cellular resource allocation by upregulating vesicle transport and fatty-acid degradation while downregulating secondary metabolism, thereby redirecting energy toward recombinant protein synthesis and secretion. Remarkably, the overexpression of msnA significantly improves the efficiency of recombinant protein secretion, even with lower transcriptional expression. In some species, this enhancement occurs despite a decrease in total secreted protein.
conclusionsOur research identifies msnA as a potential target gene for optimizing fungal cell factories, offering a framework to enhance recombinant protein production and increase the efficiency of Aspergillus-based systems in industrial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.